American association of clinical endocrinologists and american diabetes association consensus statement on inpatient glycemic control

Endocrine Practice

Volumn 15, Issue 4, 2009, Pages 353-369

  Moghissi, Etie S ^a,m   Korytkowski, Mary T ^b   DiNardo, Monica ^c   Einhorn, Daniel ^d,e,f   Hellman, Richard ^g   Hirsch, Irl B ^h   Inzucchi, Silvio E ⁱ   Ismail Beigi, Faramarz ^j   Kirkman, M Sue ^k   Umpierrez, Guillermo E ^l  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF PITTSBURGH   (United States)

^d Whittier Institute for Diabetes   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f Diabetes and Endocrine Associates   (United States)

^g UNIVERSITY OF MISSOURI KANSAS CITY SCHOOL OF MEDICINE   (United States)

^h UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

ⁱ YALE NEW HAVEN HOSPITAL   (United States)

^j CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^k AMERICAN DIABETES ASSOCIATION   (United States)

^l EMORY UNIVERSITY   (United States)

^m NONE   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR STIMULATING AGENT; GLUCOCORTICOID; GLUCOSE; HYPERTENSIVE FACTOR; INSULIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; REVIPARIN;

ACUTE HEART INFARCTION; BLOOD GLUCOSE MONITORING; CLINICAL FEATURE; CLINICAL TRIAL; COST EFFECTIVENESS ANALYSIS; DRUG EFFICACY; DRUG MEGADOSE; DRUG SAFETY; ENTERIC FEEDING; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HEALTH PRACTITIONER; HOSPITAL PATIENT; HUMAN; HYPERGLYCEMIA; HYPOGLYCEMIA; MEDICAL SOCIETY; MORTALITY; OUTPATIENT CARE; REVIEW;

EID: 67649183171     PISSN: 1530891X     EISSN: None     Source Type: Journal    
DOI: 10.4158/EP09102.RA     Document Type: Review

References (159)

1. American Diabetes Association. Economic costs of diabetes in the U.S. in 2007 [published correction appears in Diabetes Care. 2008;31:1271]. Diabetes Care. 2008;31:596-615.
2. Centers for Disease Control and Prevention. National diabetes fact sheet: general information and national estimates on diabetes in the United States, 2007. Atlanta, GA: US Department of Health and Human Services, Centers for Disease Control and Prevention, 2008.
3. Levetan CS, Passaro M, Jablonski K, Kass M, Ratner RE. Unrecognized diabetes among hospitalized patients. Diabetes Care. 1998;21:246-249.
4. Umpierrez GE, Isaacs SD, Bazargan N, You X, Thaler LM, Kitabchi AE. Hyperglycemia: an independent marker of in-hospital mortality in patients with undiagnosed diabetes. J Clin Endocrinol Metab. 2002;87:978-982.
5. Van den Berghe G, Wouters P, Weekers F, et al. Intensive insulin therapy in critically ill patients. N Engl J Med. 2001;345:1359-1367.
6. Malmberg K, Norhammar A, Wedel H, et al. Glycometabolic state at admission: important risk marker of mortality in conventionally treated patients with diabetes mellitus and acute myocardial infarction; long-term results from the Diabetes and Insulin-Glucose Infusion in Acute Myocardial Infarction (DIGAMI) study. Circulation. 1999;99:2626-2632.
7. Kosiborod M, Inzucchi SE, Goyal A, et al. The relationship between spontaneous and iatrogenic hypoglycemia and mortality in patients hospitalized with acute myocardial infarction [abstract]. Circulation. 2008;118(suppl):S1109.
8. Clement S, Braithwaite SS, Magee MF (American Diabetes Association Diabetes in Hospitals Writing Committee). Management of diabetes and hyperglycemia in hospitals [published corrections appear in Diabetes Care. 2004;27:856 and Diabetes Care. 2004;27:1255]. Diabetes Care. 2004;27:553-591.
9. Garber AJ, Moghissi ES, Bransome ED Jr, et al (American College of Endocrinology Task Force on Inpatient Diabetes and Metabolic Control). American College of Endocrinology position statement on inpatient diabetes and metabolic control. Endocr Pract. 2004;10:77-82.
10. American Diabetes Association. Standards of medical care in diabetes [published correction appears in Diabetes Care. 2005;28:990]. Diabetes Care. 2005;28(suppl 1):S4-S36.
11. ACE/ADA Task Force on Inpatient Diabetes. American College of Endocrinology and American Diabetes Association consensus statement on inpatient diabetes and glycemic control. Endocr Pract. 2006;12:458-468.
12. Wiener RS, Wiener DC, Larson RJ. Benefits and risks of tight glucose control in critically ill adults: a meta-analysis [published correction appears in JAMA. 2008;301:936]. JAMA. 2008;300:933-944.
13. Brunkhorst FM, Engel C, Bloos F, et al (German Competence Network Sepsis [SepNet]). Intensive insulin therapy and pentastarch resuscitation in severe sepsis. N Engl J Med. 2008;358:125-139.
14. Finfer S, Chittock DR, Su SY, et al (NICE-SUGAR Study Investigators). Intensive versus conventional glucose control in critically ill patients. N Engl J Med. 2009;360:283-1297.
15. Krinsley JS, Grover A. Severe hypoglycemia in critically ill patients: risk factors and outcomes. Crit Care Med. 2007;35:2262-2267.
16. Van den Berghe G, Wilmer A, Hermans G, et al. Intensive insulin therapy in the medical ICU. N Engl J Med. 2006;354:449-461.
17. Griesdale DE, de Souza RJ, van Dam RM, et al. Intensive insulin therapy and mortality among critically ill patients: a meta-analysis including NICE-SUGAR study data [published online ahead of print March 24, 2009]. CMAJ. doi:10.1503/cmaj.090206.
18. Malmberg K (DIGAMI [Diabetes Mellitus, Insulin Glucose Infusion in Acute Myocardial Infarction] Study Group). Prospective randomised study of intensive insulin treatment on long term survival after acute myocardial infarction in patients with diabetes mellitus. BMJ. 1997;314:1512-1515.
19. Furnary AP, Zerr KJ, Grunkemeier GL, Starr A. Continuous intravenous insulin infusion reduces the incidence of deep sternal wound infection in diabetic patients after cardiac surgical procedures [with discussion]. Ann Thorac Surg. 1999;67:352-362.
20. Latham R, Lancaster AD, Covington JF, Pirolo JS, Thomas CS. The association of diabetes and glucose control with surgical site infections among cardiothoracic surgery patients. Infec Control Hosp Epidemiol. 2001;22:607-612.
21. Sala J, Masi á R, Gonz ález de Molina FJ, et al (REGICOR Investigators). Short-term mortality of myocardial infarction patients with diabetes or hyperglycaemia during admission.J Epidemiol Community Health. 2002;56:707-712.
22. Furnary AP, Gao G, Grunkemeier GL, et al. Continuous insulin infusion reduces mortality in patients with diabetes undergoing coronary artery bypass grafting. J Thorac Cardiovasc Surg. 2003;125:1007-1021.
23. Krinsley JS. Effect of intensive glucose management protocol on the mortality of critically ill adult patients [published correction appears in Mayo Clin Proc. 2005;80:1101]. Mayo Clin Proc. 2004;79:992-1000.
24. Pittas AG, Siegel RD, Lau J. Insulin therapy for critically ill hospitalized patients: a meta-analysis of randomized, controlled trials. Arch Intern Med. 2004;164:2005-2011.
25. Ishihara M, Kojima S, Sakamoto T, et al (Japanese Acute Coronary Syndrome Study Investigators). Acute hyperglycemia is associated with adverse outcome after acute myocardial infarction in the coronary intervention era. Am Heart J. 2005;150:814-820.
26. Mizock BA. Alterations in carbohydrate metabolism during stress: a review of the literature. Am J Med. 1995;98:75-84.
27. Devos P, Preiser JC, M élot C (GluControl Steering Committee). Impact of tight glucose control by intensive insulin therapy on ICU mortality and the rate of hypoglycaemia: final results of the GluControl study [abstract]. Intensive Care Med. 2007;33:S189.
28. De La Rosa GD, Donado JH, Restrepo AH, et al (Grupo de Investigacion en Cuidado Intensivo [GICIHPTU]). Strict glycaemic control in patients hospitalised in a mixed medical and surgical intensive care unit: a randomised clinical trial. Crit Care. 2008;12:R120.
29. Finfer S, Delaney A. Tight glycemic control in critically ill adults. JAMA. 2008;300:963-965.
30. Golden SH, Peart-Vigilance C, Kao WH, Brancati FL. Perioperative glycemic conrol and the risk of infectious complications in a cohort of adults with diabetes. Diabetes Care. 1999;22:1408-1414.
31. Zerr KJ, Furnary AP, Grunkemeier GL, Bookin S, Kanhere V, Starr A. Glucose control lowers the risk of wound infection in diabetics after open heart operations. Ann Thorac Surg. 1997;63:356-361.
32. Krinsley JS. Glycemic control, diabetic status, and mortality in a heterogeneous population of critically ill patients before and during the era of intensive glycemic management: six and one-half years experience at a universityaffiliated community hospital. Semin Thorac Cardiovasc Surg. 2006;18:317-325.
33. Malmberg K, Ryd én L, Efendic S, et al. Randomized trial of insulin-glucose infusion followed by subcutaneous insulin treatment in diabetic patients with acute myocardial infarction (DIGAMI study): effects on mortality at 1 year. J Am Coll Cardiol. 1995;26:57-65.
34. Malmberg K, Ryd én L, Wedel H, et al (DIGAMI 2 Investigators). Intense metabolic control by means of insulin in patients with diabetes mellitus and acute myocardial infarction (DIGAMI 2): effects on mortality and morbidity. Eur Heart J. 2005;26:650-661.
35. Cheung NW, Wong VW, McLean M. The Hyperglycemia: Intensive Insulin Infusion in Infarction (HI-5) study; a randomized controlled trial of insulin infusion therapy for myocardial infarction. Diabetes Care. 2006;29:765-770.
36. Gandhi GY, Nuttall GA, Abel MD, et al. Intensive intraoperative insulin therapy versus conventional glucose management during cardiac surgery: a randomized trial. Ann Intern Med. 2007;146:233-243.
37. Capes SE, Hunt D, Malmberg K, Gerstein HC. Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systematic overview. Lancet. 2000;355:773-778.
38. Kosiborod M, Rathore SS, Inzucchi SE, et al. Admission glucose and mortality in elderly patients hospitalized with acute myocardial infarction: implications for patients with and without recognized diabetes. Circulation. 2005;111:3078-3086.
39. Kosiborod M, Inzucchi SE, Krumholz HM, et al. Glucometrics in patients hospitalized with acute myocardial infarction: defining the optimal outcomes-based measure of risk. Circulation. 2008;117:1018-1027.
40. Goyal A, Mahaffey KW, Garg J, et al. Prognostic significance of the change in glucose level in the first 24 h after acute myocardial infarction: results from the CARDINAL study. Eur Heart J. 2006;27:1289-1297.
41. Deedwania P, Kosiborod M, Barrett E, et al (American Heart Association Diabetes Committee of the Council on Nutrition, Physical Activity, and Metabolism). Hyperglycemia and acute coronary syndrome: a scientific statement from the American Heart Association Diabetes Committee of the Council on Nutrition, Physical Activity, and Metabolism. Circulation. 2008;117:1610-1619.
42. Pinto DS, Skolnick AH, Kirtane AJ, et al (TIMI Study Group). U-shaped relationship of blood glucose with adverse outcomes among patients with ST-segment elevation myocardial infarction. J Am Coll Cardiol. 2005;46:178-180.
43. Svensson AM, McGuire DK, Abrahamsson P, Dellborg M. Association between hyper- and hypoglycaemia and 2 year all-cause mortality risk in diabetic patients with acute coronary events. Eur Heart J. 2005;26:1255-1261.
44. Mehta SR, Yusuf S, Diaz R, et al (CREATE-ECLA Trial Group Investigators). Effect of glucose-insulin-potassium infusion on mortality in patients with acute ST-segment elevation myocardial infarction: the CREATE-ECLA randomized controlled trial. JAMA. 2005;293:437-446.
45. Laird AM, Miller PR, Kilgo PD, Meredith JW, Chang MC. Relationship of early hyperglycemia to mortality in trauma patients. J Trauma. 2004;56:1058-1062.
46. Jeremitsky E, Omert LA, Dunham CM, Wilberger J, Rodriguez A. The impact of hyperglycemia on patients with severe brain injury. J Trauma. 2005;58:47-50.
47. Gale SC, Sicoutris C, Reilly PM, Schwab CW, Gracias VH. Poor glycemic control is associated with increased mortality in critically ill trauma patients. Am Surg. 2007;73:454-460.
48. Vogelzang M, van der Horst ICC, Nijsten MW. Hyperglycaemic index as a tool to assess glucose control: a retrospective study. Crit Care. 2004;8:R122- R127.
49. Duane TM, Ivatury RR, Dechert T, et al. Blood glucose levels at 24 hours after trauma fails to predict outcomes. J Trauma. 2008;64:1184-1187.
50. Cochran A, Davis L, Morris SE, Saffle JR. Safety and efficacy of an intensive insulin protocol in a burn-trauma intensive care unit. J Burn Care Res. 2008;29:187-191.
51. Wahl WL, Taddonio M, Maggio PM, Arbabi S, Hemmila MR. Mean glucose values predict trauma patient mortality. J Trauma. 2008;65:42-47.
52. Pasternak JJ, McGregor DG, Schroeder DR, et al (IHAST Investigators). Hyperglycemia in patients undergoing cerebral aneurysm surgery: its association with longterm gross neurologic and neuropsychological function. Mayo Clin Proc. 2008;83:406-417.
53. Mowery NT, Gunter OL, Guillamondegui O, et al. Stress insulin resistance is a marker for mortality in traumatic brain injury [with discussion]. J Trauma. 2009;66:145-153.
54. Sung J, Bochicchio GV, Joshi M, Bochicchio K, Tracy K, Scalea TM. Admission hyperglycemia is predictive of outcome in critically ill trauma patients. J Trauma. 2005;59:80-83.
55. Bochicchio GV, Joshi M, Bochicchio KM, et al. Early hyperglycemic control is important in critically injured trauma patients. J Trauma. 2007;63:1353-1358.
56. Yendamuri S, Fulda GJ, Tinkoff GH. Admission hyperglycemia as a prognostic indicator in trauma. J Trauma. 2003;55:33-38.
57. Collier B, Diaz J Jr, Forbes R, et al. The impact of a normoglycemic management protocol on clinical outcomes in the trauma intensive care unit [with discussion]. JPEN J Parenter Enteral Nutr. 2005;29:353-359.
58. Shin S, Britt RC, Reed SF, Collins J, Weireter LJ, Britt LD. Early glucose normalization does not improve outcome in the critically ill trauma population. Am Surg. 2007;73:769-772.
59. Bilotta F, Caramia R, Cernak I, et al. Intensive insulin therapy after severe traumatic brain injury: a randomized clinical trial. Neurocrit Care. 2008;9:159-166.
60. Davidson JA, Wilkinson A (International Expert Panel on New-Onset Diabetes After Transplantation). New-Onset Diabetes After Transplantation 2003 International Consensus Guidelines: an endocrinologist 's view. Diabetes Care. 2004;27:805-812.
61. Fuji S, Kim SW, Mori S, et al. Hyperglycemia during the neutropenic period is associated with a poor outcome in patients undergoing myeloablative allogeneic hematopoietic stem cell transplantation. Transplantation. 2007;84:814-820.
62. Derr RL, Hsiao VC, Saudek CD. Antecedent hyperglycemia is associated with an increased risk of neutropenic infections during bone marrow transplantation. Diabetes Care. 2008;31:1972-1977.
63. Hammer MJ, Casper C, Gooley TA, O 'Donnell PV, Boeckh M, Hirsch IB. The contribution of malglycemia to mortality among allogeneic hematopoietic cell transplant recipients. Biol Blood Marrow Transplant. 2009;15:344-351.
64. Shim YH, Kweon TD, Lee JH, Nam SB, Kwak YL. Intravenous glucose-insulin-potassium during off-pump coronary artery bypass surgery does not reduce myocardial injury. Acta Anaesthesiol Scand. 2006;50:954-961.
65. Wintergerst KA, Buckingham B, Gandrud L, Wong BJ, Kachce S, Wilson DM. Association of hypoglycemia, hyperglycemia, and glucose variability with morbidity and death in the pediatric intensive care unit. Pediatrics. 2006;118:173-179.
66. Palacio A, Smiley D, Ceron M, et al. Prevalence and clinical outcome of inpatient hyperglycemia in a community pediatric hospital. J Hosp Med. 2008;3:212-217.
67. Faustino EV, Apkon M. Persistent hyperglycemia in critically ill children. J Pediatr. 2005;146:30-34.
68. Branco RG, Garcia PC, Piva JP, Casartelli CH, Seibel V, Tasker RC. Glucose level and risk of mortality in pediatric septic shock. Pediatr Crit Care Med. 2005;6:470-472.
69. Tuggle DW, Kuhn MA, Jones SK, Garza JJ, Skinner S. Hyperglycemia and infections in pediatric trauma patients. Am Surg. 2008;74:195-198.
70. Falcao G, Ulate K, Kouzekanani K, Bielefeld MR, Morales JM, Rotta AT. Impact of postoperative hyperglycemia following surgical repair of congenital cardiac defects. Pediatr Cardiol. 2008;29:628-636.
71. Beardsall K, Vanhaesebrouck S, Ogilvy-Stuart AL, et al. Early insulin therapy in very-low-birth-weight infants. N Engl J Med. 2008;359:1873-1884.
72. Vlasselaers D, Milants I, Desmet L, et al. Intensive insulin therapy for patients in paediatric intensive care: a prospective, randomised controlled study. Lancet. 2009;373:547-556.
73. Pomposelli JJ, Baxter JK III, Babineau TJ, et al. Early postoperative glucose control predicts nosocomial infection rate in diabetic patients. JPEN J Parenter Enteral Nutr. 1998;22:77-81.
74. Capes SE, Hunt D, Malmberg K, Pathak P, Gerstein HC. Stress hyperglycemia and prognosis of stroke in nondiabetic and diabetic patients: a systematic overview. Stroke. 2001;32:2426-2432.
75. Bruno A, Gregori D, Caropreso A, Lazzarato F, Petrinco M, Pagano E. Normal glucose values are associated with a lower risk of mortality in hospitalized patients. Diabetes Care. 2008;31:2209-2210.
76. Norhammar AM, Ryd én L, Malmberg K. Admission plasma glucose: independent risk factor for long-term prognosis after myocardial infarction even in nondiabetic patients. Diabetes Care. 1999;22:1827-1831.
77. Finney SJ, Zekveld C, Elia A, Evans TW. Glucose control and mortality in critically ill patients. JAMA. 2003;290: 2041-2047.
78. Montori VM, Bistrian BR, McMahon MM. Hyperglycemia in acutely ill patients. JAMA. 2002;288:2167-2169.
79. Noordzij PG, Boersma E, Schreiner F, et al. Increased preoperative glucose levels are associated with perioperative mortality in patients undergoing noncardiac, nonvascular surgery. Eur J Endocrinol. 2007;156:137-142.
80. McAlister FA, Majumdar SR, Blitz S, Rowe BH, Romney J, Marrie TJ. The relation between hyperglycemia and outcomes in 2,471 patients admitted to the hospital with community-acquired pneumonia. Diabetes Care. 2005;28:810-815.
81. Baker EH, Janaway CH, Philips BJ, et al. Hyperglycaemia is associated with poor outcomes in patients admitted to hospital with acute exacerbations of chronic obstructive pulmonary disease. Thorax. 2006;61:284-289.
82. Egi M, Bellomo R, Stachowski E, French CJ, Hart G. Variability of blood glucose concentration and short-term mortality in critically ill patients. Anesthesiology. 2006;105:244-252.
83. Hirsch IB, Brownlee M. Should minimal blood glucose variability become the gold standard of glycemic control? J Diabetes Complications. 2005;19:178-181.
84. Inzucchi SE, Siegel MD. Glucose control in the ICU -how tight is too tight? N Engl J Med. 2009;360:1346-1349.
85. American Diabetes Association. Standards of medical care in diabetes -2009. Diabetes Care. 2009;32(suppl 1):S13-S61.
86. Rodbard HW, Blonde L, Braithwaite SS, et al (AACE Diabetes Mellitus Clinical Practice Guidelines Task Force). American Association of Clinical Endocrinologists medical guidelines for clinical practice for the management of diabetes mellitus [published correction appears in Endocr Pract. 2008;14:802-803]. Endocr Pract. 2007;13(suppl 1):1-68.
87. Saudek CD, Herman WH, Sacks DB, Bergenstal RM, Edelman D, Davidson MB. A new look at screening and diagnosing diabetes mellitus. J Clin Endocrinol Metab. 2008;93:2447-2453.
88. Cryer PE, Davis SN, Shamoon H. Hypoglycemia in diabetes. Diabetes Care. 2003;26:1902-1912.
89. Mitrakou A, Ryan C, Veneman T, et al. Hierarchy of glycemic thresholds for counterregulatory hormone secretion, symptoms, and cerebral dysfunction. Am J Physiol. 1991;260(1, pt 1):E67-E74.
90. Korytkowski MT, DiNardo M, Donihi AC, Bigi L, DeVita M. Evolution of a diabetes inpatient safety committee. Endocr Pract. 2006;12(suppl 3):91-99.
91. DiNardo MM, Noschese M, Korytkowski MT, Freeman S. The medical emergency team and rapid response system: finding, treating, and preventing hypoglycemia. Jt Comm J Qual Patient Saf. 2006;32:591-595.
92. DiNardo M, Donihi AC, DeVita M, Siminerio L, Rao H, Korytkowski MT. A nurse directed protocol for recognition and treatment of hypoglycemia in hospitalized patients. Pract Diabetol. 2005;22:37-40.
93. Donihi AC, Raval D, Saul M, Korytkowski MT, DeVita MA. Prevalence and predictors of corticosteroid-related hyperglycemia in hospitalized patients. Endocr Pract. 2006;12:358-362.
94. Curll M, DiNardo M, Noschese M, Korytkowski MT. Menu selection, glycaemic control, and satisfaction with standard and patient-controlled consistent carbohydrate meal plans in hospitalized patients with diabetes. Qual Saf Health Care. 2009. In press.
95. Goldberg PA, Bozzo JE, Thomas PG, et al. "Glucometrics " -assessing the quality of inpatient glucose management. Diabetes Technol Ther. 2006;8:560-569.
96. Donihi A, Rea R, Mihalko M, Korytkowski M . Comparison of different methods of transitioning MICU patients from intravenous to subcutaneous insulin [abstract]. Diabetes. 2007;57:A542.
97. Moghissi ES. Insulin strategies for managing inpatient and outpatient hyperglycemia and diabetes. Mt Sinai J Med. 2008;75:558-566.
98. Goldberg PA, Siegel MD, Sherwin RS, et al. Implementation of a safe and effective insulin infusion protocol in a medical intensive care unit. Diabetes Care. 2004;27: 461-467.
99. Rea RS, Donihi AC, Bobeck M, et al. Implementing an intravenous insulin infusion protocol in the intensive care unit. Am J Health Syst Pharm. 2007;64:385-395.
100. Nazer LH, Chow SL, Moghissi ES. Insulin infusion protocols for critically ill patients: a highlight of differences and similarities. Endocr Pract. 2007;13:137-146.
101. DeSantis AJ, Schmeltz LR, Schmidt K, et al. Inpatient management of hyperglycemia: the Northwestern experience. Endocr Pract. 2006;12:491-505.
102. Noschese M, Donihi AC, Koerbel G, et al. Effect of a diabetes order set on glycaemic management and control in the hospital. Qual Saf Health Care. 2008;17:464-468.
103. Noschese M, Donihi A, Ruppert K, et al. A guideline for diabetes self management in the hospital: experience with 50 patients using continuous insulin infusions. Paper presented at: 67th Scientific Sessions of the American Diabetes Association; June 22-26, 2007; Chicago, IL.
104. Umpierrez GE, Hor T, Smiley D, et al. Comparison of inpatient insulin regimens with detemir plus aspart versus neutral protamine Hagedorn plus regular in medical patients with type 2 diabetes. J Clin Endocrinol Metab. 2009;94:564-569.
105. Moghissi ES, Hirsch IB. Hospital management of diabetes. Endocrinol Metab Clin North Am. 2005;34:99-116.
106. Umpierrez GE, Smiley D, Zisman A, et al. Randomized study of basal-bolus insulin therapy in the inpatient management of patients with type 2 diabetes (RABBIT 2 trial). Diabetes Care. 2007;30:2181-2186.
107. Umpierrez GE, Palacio A, Smiley D. Sliding scale insulin use: myth or insanity? Am J Med. 2007;120:563-567.
108. Queale WS, Seidler AJ, Brancati FL. Glycemic control and sliding scale insulin use in medical inpatients with diabetes mellitus. Arch Intern Med. 1997;157:545-552.
109. Korytkowski MT, Salata RJ, Koerbel GL, et al. Insulin therapy and glycemic control in hospitalized patients with diabetes during enteral nutrition therapy: a randomized controlled clinical trial. Diabetes Care. 2009;32:594-596.
110. Schnipper JL, Barsky EE, Shaykevich S, Fitzmaurice G, Pendergrass ML. Inpatient management of diabetes and hyperglycemia among general medicine patients at a large teaching hospital. J Hosp Med. 2006;1:145-150.
111. Hirsch IB. Sliding scale insulin -time to stop sliding. JAMA. 2009;301:213-214.
112. Umpierrez GE. Basal versus sliding-scale regular insulin in hospitalized patients with hyperglycemia during enteral nutrition therapy. Diabetes Care. 2009;32:751-753.
113. Donihi AC, Yang E, Mark SM, Sirio CA, Weber RJ. Scheduling of pharmacist-provided medication education for hospitalized patients. Hosp Pharm. 2008;43:121-126.
114. Cook CB, Boyle ME, Cisar NS, et al. Use of continuous subcutaneous insulin infusion (insulin pump) therapy in the hospital setting: proposed guidelines and outcomes measures [published correction appears in Diabetes Educ. 2006;32:130]. Diabetes Educ. 2005;31:849-857.
115. Bailon RM, Partlow BJ, Miller-Cage V, et al. Continuous subcutaneous insulin infusion (insulin pump) therapy can be safely used in the hospital in select patients. Endocr Pract. 2009;15:24-29.
116. Pancorbo-Hidalgo PL, Garc ía-Fernandez FP, Ram írez- P érez C. Complications associated with enteral nutrition by nasogastric tube in an internal medicine unit. J Clin Nurs. 2001;10:482-490.
117. Arinzon Z, Shabat S, Shuval I, Peisakh A, Berner Y . Prevalence of diabetes mellitus in elderly patients received enteral nutrition long-term care service. Arch Gerontol Geriatr. 2008;47:383-393.
118. Nylen ES, Muller B. Endocrine changes in critical illness. J Intensive Care Med. 2004;19:67-82.
119. Reider J, Lin H, Dinardo M, Donihi A, Saul M, Korytkowski M. Efficacy of a guideline for treatment of corticosteroid related hyperglycemia in the hospital [abstract]. Diabetes. 2008;57:A574.
120. Hellman R. A systems approach to reducing errors in insulin therapy in the inpatient setting. Endocr Pract. 2004; 10(suppl 2):100-108.
121. Hellman R. Patient safety and inpatient glycemic control: translating concepts into action. Endocr Pract. 2006; 12(suppl 3):49-55.
122. Cryer PE. Hypoglycaemia: the limiting factor in the glycaemic management of the critically ill? Diabetologia. 2006;49:1722-1725.
123. Cook CB, Castro JC, Schmidt RE, et al. Diabetes care in hospitalized noncritically ill patients: more evidence for clinical inertia and negative therapeutic momentum. J Hosp Med. 2007;2:203-211.
124. Braithwaite SS, Buie MM, Thompson CL, et al. Hospital hypoglycemia: not only treatment but also prevention. Endocr Pract. 2004;10(suppl 2):89-99.
125. Knecht LA, Gauthier SM, Castro JC, et al. Diabetes care in the hospital: is there clinical inertia? J Hosp Med. 2006;1:151-160.
126. Flansbaum B. Management of hyperglycemia. J Hosp Med. 2006;1:382-385.
127. Cook CB, Jameson KA, Hartsell ZC, et al. Beliefs about hospital diabetes and perceived barriers to glucose management among inpatient midlevel practitioners. Diabetes Educ. 2008;34:75-83.
128. Smith WD, Winterstein AG, Johns T, Rosenberg E, Sauer BC. Causes of hyperglycemia and hypoglycemia in adult inpatients. Am J Health Syst Pharm. 2005;62:714-719.
129. Seley J, Wallace M. Meeting the challenge of inpatient diabetes education: an interdisciplinary approach. In: Weinger K, Carver C, eds. Educating Your Patient With Diabetes. Totowa, New Jersey: Humana Press, 2009: 81-96. http://www.springerlink.com/content/m646r4l21x476x45/.Accessed for verification April 7, 2009.
130. van der Crabben SN, Bl ümer RM, Stegenga ME, et al . Early endotoxemia increases peripheral and hepatic insulin sensitivity in healthy humans. J Clin Endocrinol Metab. 2009;94:463-468.
131. Taylor BE, Schallom ME, Sona CS, et al. Efficacy and safety of an insulin infusion protocol in a surgical ICU. J Am Coll Surg. 2006;202:1-9.
132. Cryer PE. Diverse causes of hypoglycemia-associated autonomic failure in diabetes. N Engl J Med. 2004;350: 2272-2279.
133. Rubin DJ, Moshang J, Jabbour SA. Diabetes knowledge: are resident physicians and nurses adequately prepared to manage diabetes? Endocr Pract. 2007;13:17-21.
134. Lansang MC, Harrell H. Knowledge on inpatient diabetes among fourth-year medical students. Diabetes Care. 2007;30:1088-1091.
135. Baldwin D, Villanueva G, McNutt R, Bhatnagar S . Eliminating inpatient sliding-scale insulin: a reeducation project with medical house staff. Diabetes Care. 2005;28:1008-1011.
136. Cohen MR, Proulx SM, Crawford SY. Survey of hospital systems and common serious medication errors. J Healthc Risk Manag. 1998;18:16-27.
137. Amori RE, Pittas AG, Siegel RD, et al. Inpatient medical errors involving glucose-lowering medications and their impact on patients: review of 2,598 incidents from a voluntary electronic error-reporting database. Endocr Pract. 2008;14:535-542.
138. Scott MG, Bruns DE, Boyd JC, Sacks DB. Tight glucose control in the intensive care unit: are glucose meters up to the task? Clin Chem. 2009;55:18-20.
139. D 'Orazio P, Burnett RW, Fogh-Andersen N, et al (International Federation of Clinical Chemistry Scientific Division Working Group on Selective Electrodes and Point of Care Testing). Approved IFCC recommendation on reporting results for blood glucose (abbreviated). Clin Chem. 2005;51:1573-1576.
140. Dungan K, Chapman J, Braithwaite SS, Buse J. Glucose measurement: confounding issues in setting targets for inpatient management. Diabetes Care. 2007;30:403-409.
141. Boyd JC, Bruns DE. Quality specifications for glucose meters: assessment simulation modeling of errors in insulin dose. Clin Chem. 2001;47:209-214.
142. Goldberg PA, Siegel MD, Russell RR, et al. Experience with the continuous glucose monitoring system in a medical intensive care unit. Diabetes Technol Ther. 2004;6:339-347.
143. Murakami A, Gutierrez MA, Lage SH, Rebelo MF, Guiraldelli RH, Ramires JA. A continuous glucose monitoring system in critical cardiac patients in the intensive care unit. Comput Cardiol. 2006;17-20:233-236.
144. Page A, ed. (Committee on the Work Environment for Nurses and Patient Safety, Board on Health Care Services, Institute of Medicine of the National Academies). Keeping Patients Safe: Transforming the Work Environment of Nurses. Washington, DC: National Academies Press, 2004.
145. Bates D, Clark NG, Cook RI, et al (Writing Committee on Patient Safety and Medical System Errors in Diabetes and Endocrinology). American College of Endocrinology and American Association of Clinical Endocrinologists position statement on patient safety and medical system errors in diabetes and endocrinology. Endocr Pract. 2005;11:197-202.
146. Bates DW, Leape LL, Cullen DJ, et al. Effect of computerized physician order entry and a team intervention on prevention of serious medical errors. JAMA. 1998;280: 1311-1316.
147. Bates DW, Gawande AA. Improving patient safety with information technology. N Engl J Med. 2003;348: 2526-2534.
148. Furnary AP, Wu Y, Bookin SO. Effect of hyperglycemia and continuous intravenous insulin infusions on outcomes of cardiac surgical procedures: the Portland Diabetic Project. Endocr Pract. 2004;10(suppl 2):21-33.
149. Krinsley JS, Jones RL. Cost analysis of intensive glycemic control in critically ill adult patients. Chest. 2006;129: 644-650.
150. Van den Berghe G, Wouters PJ, Kesteloot K, Hilleman DE. Analysis of healthcare resource utilization with intensive insulin therapy in critically ill patients. Crit Care Med. 2006;34:612-616.
151. Estrada CA, Young JA, Nifong LW, Chitwood WR Jr . Outcomes and perioperative hyperglycemia in patients with or without diabetes mellitus undergoing coronary artery bypass grafting. Ann Thorac Surg. 2003;75:1392-1399.
152. Newton CA, Young S. Financial implications of glycemic control: results of an inpatient diabetes management program. Endocr Pract. 2006;12(suppl 3):43-48.
153. Munoz C, Villanueva G, Fogg L, et al. Impact of a subcutaneous insulin protocol in the emergency department: Rush Emergency Department Hyperglycemia Intervention (REDHI) [published online ahead of print September 29, 2008]. J Emerg Med. 2008.
154. Olson L, Muchmore J, Lawrence CB. The benefits of inpatient diabetes care: improving quality of care and the bottom line. Endocr Pract. 2006;12(suppl 3):35-42.
155. Levetan CS, Salas JR, Wilets IF, Zumoff B. Impact of endocrine and diabetes team consultation on hospital length of stay for patients with diabetes. Am J Med. 1995;99:22-28.
156. Kripalani S, Jackson AT, Schnipper JL, Coleman EA . Promoting effective transitions of care at hospital discharge: a review of key issues for hospitalists. J Hosp Med. 2007;2:314-323.
157. Forster AJ, Murff HJ, Peterson JF, Gandhi TK, Bates DW. The incidence and severity of adverse events affecting patients after discharge from the hospital. Ann Intern Med. 2003;138:161-167.
158. Large BE. Providing timely discharge counseling. Am J Health Syst Pharm. 1999;56:1074-1077.
159. Lauster CD, Gibson JM, DiNella JV, DiNardo M, Korytkowski MT. Implementation of standardized instructions for insulin at hospital discharge. J Hosp Med. In press.